![Exosomes as prognostic biomarkers in pancreatic ductal adenocarcinoma—a systematic review and meta-analysis - Translational Research Exosomes as prognostic biomarkers in pancreatic ductal adenocarcinoma—a systematic review and meta-analysis - Translational Research](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/0719e065-5931-4cda-b92e-f3a1a49c1950/gr1_lrg.jpg)
Exosomes as prognostic biomarkers in pancreatic ductal adenocarcinoma—a systematic review and meta-analysis - Translational Research
![Death in hospital following ICU discharge: insights from the LUNG SAFE study | Critical Care | Full Text Death in hospital following ICU discharge: insights from the LUNG SAFE study | Critical Care | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs13054-021-03465-0/MediaObjects/13054_2021_3465_Fig1_HTML.png)
Death in hospital following ICU discharge: insights from the LUNG SAFE study | Critical Care | Full Text
![Impact of BCR::ABL1 transcript type on RT-qPCR amplification performance and molecular response to therapy | Leukemia Impact of BCR::ABL1 transcript type on RT-qPCR amplification performance and molecular response to therapy | Leukemia](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41375-022-01612-2/MediaObjects/41375_2022_1612_Fig6_HTML.png)
Impact of BCR::ABL1 transcript type on RT-qPCR amplification performance and molecular response to therapy | Leukemia
![Frontiers | Liquid Biopsy as a Prognostic and Theranostic Tool for the Management of Pancreatic Ductal Adenocarcinoma Frontiers | Liquid Biopsy as a Prognostic and Theranostic Tool for the Management of Pancreatic Ductal Adenocarcinoma](https://www.frontiersin.org/files/Articles/788869/fmed-08-788869-HTML/image_m/fmed-08-788869-t001.jpg)
Frontiers | Liquid Biopsy as a Prognostic and Theranostic Tool for the Management of Pancreatic Ductal Adenocarcinoma
![COVID-19 in patients with cancer: first report of the ESMO international, registry-based, cohort study (ESMO-CoCARE) - ESMO Open COVID-19 in patients with cancer: first report of the ESMO international, registry-based, cohort study (ESMO-CoCARE) - ESMO Open](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/asset/15967dee-905d-4f55-a2a0-e9f3d56c6027/gr1.jpg)
COVID-19 in patients with cancer: first report of the ESMO international, registry-based, cohort study (ESMO-CoCARE) - ESMO Open
![Standardization of molecular monitoring of CML: results and recommendations from the European treatment and outcome study | Leukemia Standardization of molecular monitoring of CML: results and recommendations from the European treatment and outcome study | Leukemia](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41375-022-01607-z/MediaObjects/41375_2022_1607_Fig1_HTML.png)
Standardization of molecular monitoring of CML: results and recommendations from the European treatment and outcome study | Leukemia
![Potential of FX06 to prevent disease progression in hospitalized non-intubated COVID-19 patients — the randomized, EU-wide, placebo-controlled, phase II study design of IXION | Trials | Full Text Potential of FX06 to prevent disease progression in hospitalized non-intubated COVID-19 patients — the randomized, EU-wide, placebo-controlled, phase II study design of IXION | Trials | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs13063-022-06609-x/MediaObjects/13063_2022_6609_Fig1_HTML.png)
Potential of FX06 to prevent disease progression in hospitalized non-intubated COVID-19 patients — the randomized, EU-wide, placebo-controlled, phase II study design of IXION | Trials | Full Text
![COVID-19 in patients with cancer: first report of the ESMO international, registry-based, cohort study (ESMO-CoCARE) - ESMO Open COVID-19 in patients with cancer: first report of the ESMO international, registry-based, cohort study (ESMO-CoCARE) - ESMO Open](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/3eaa3481-8e07-40a9-bd4b-504678e1e252/gr2_lrg.jpg)
COVID-19 in patients with cancer: first report of the ESMO international, registry-based, cohort study (ESMO-CoCARE) - ESMO Open
![COVID-19 in liver transplant candidates: pretransplant and post-transplant outcomes - an ELITA/ELTR multicentre cohort study | Gut COVID-19 in liver transplant candidates: pretransplant and post-transplant outcomes - an ELITA/ELTR multicentre cohort study | Gut](https://gut.bmj.com/content/gutjnl/70/10/1914/F1.large.jpg)
COVID-19 in liver transplant candidates: pretransplant and post-transplant outcomes - an ELITA/ELTR multicentre cohort study | Gut
Immunoglobulin Response and Prognostic Factors in Repeated SARS-CoV-2 Positive Patients: A Systematic Review and Meta-Analysis
![Impact of BCR::ABL1 transcript type on RT-qPCR amplification performance and molecular response to therapy | Leukemia Impact of BCR::ABL1 transcript type on RT-qPCR amplification performance and molecular response to therapy | Leukemia](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41375-022-01612-2/MediaObjects/41375_2022_1612_Fig5_HTML.png)
Impact of BCR::ABL1 transcript type on RT-qPCR amplification performance and molecular response to therapy | Leukemia
![Prognostic role of cell-free DNA biomarkers in pancreatic adenocarcinoma: A systematic review and meta–analysis - ScienceDirect Prognostic role of cell-free DNA biomarkers in pancreatic adenocarcinoma: A systematic review and meta–analysis - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S1040842821003358-ga1.jpg)